Literature DB >> 33559676

Pregnancy in women with cardiac disease: a one-year retrospective review of management and maternal and neonatal outcomes in a tertiary hospital in Johannesburg, South Africa.

Irina Balieva1, Lawrence Chauke2, Amy Wise3, Adriaan A Voors4, Elise Schapkaitz2, Hendrik Lombaard3, Haroun A Rhemtula2.   

Abstract

INTRODUCTION: In South Africa, cardiac disease continues to be the most important non-obstetric cause of maternal death.
METHODS: A record review of 74 pregnant women with cardiac disease was performed to determine the prevalence and outcomes of cardiac disease at Charlotte Maxeke Johannesburg Academic Hospital between January and December 2017.
RESULTS: Rheumatic heart disease was the most common cardiac diagnosis (n = 21, 28.4%), followed by pulmonary hypertension (n = 13, 17.6%) and congenital heart disease (n = 12, 16.2%). There were one (1.4%) maternal and two (2.7%) perinatal deaths. Neonatal complications included pre-term delivery (n = 20, 32.3%) and small-for-gestational-age infants (n = 10, 16.1%). Cardiac complications (n = 30, 40.5%) included heart failure (n = 15, 20.3%), pulmonary hypertension (n = 11, 14.9%) and blood transfusions (n = 8, 10.8%).
CONCLUSIONS: Cardiac disease in pregnancy was associated with a high risk of maternal and neonatal complications. Pre-conceptual counselling and managing pregnant women at a dedicated centre by a multidisciplinary team could, however, improve outcomes.

Entities:  

Keywords:  cardiac disease in pregnancy; anticoagulation in pregnancy; modified World Health Organisation classification; rheumatic heart disease; valvular heart disease

Mesh:

Year:  2021        PMID: 33559676      PMCID: PMC8756042          DOI: 10.5830/CVJA-2020-062

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   1.167


  1 in total

1.  Targeting Myadm to Intervene Pulmonary Hypertension on Rats Before Pregnancy Alleviates the Effect on Their Offspring's Cardiac-Cerebral Systems.

Authors:  Jingrong Wang; Zirui Zhang; Cui Liang; Tingting Lv; Haoying Yu; Shuyue Ren; Peirong Lin; Guanhua Du; Lan Sun
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.